go back

Prochlorperazine, Oral

Vermont rates for HCPCS Q0164

Prochlorperazine maleate, 5 mg, oral, FDA-approved prescription antiemetic, for use as a complete therapeutic substitute for an IV antiemetic at the time of chemotherapy treatment, not to exceed a 48-hour dosage regimen

Rates data updated July 2026.

Facilitymedian $1 · 10th–90th $1$10%50%100%$1Professionalmedian $0 · 10th–90th $0$00%50%10th90th$0$0.1$0.1$0.2$0.5$1.0

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Professional
Modifier
Global
Typical Low
$0.16
Median
$0.35
Typical High
$0.36
Cigna
Setting
Professional
Modifier
Global
Typical Low
$0.35
Median
$0.35
Typical High
$0.35
United
Setting
Facility
Modifier
Global
Typical Low
$0.87
Median
$0.87
Typical High
$0.87
United
Setting
Professional
Modifier
Global
Typical Low
$0.32
Median
$0.34
Typical High
$0.66